299916-67-9

Basic information

• Product Name: 4H-1,3-Dioxolo4,5-cpyrrole-4-methanol, tetrahydro-6-4-methoxy-5-(phenylmethoxy)methyl-5H-pyrrolo3,2-dpyrimidin-7-yl-2,2-dimethyl-, (3aR,4R,6S,6aS)-
• Synonyms: 4H-1,3-Dioxolo4,5-cpyrrole-4-methanol, tetrahydro-6-4-methoxy-5-(phenylmethoxy)methyl-5H-pyrrolo3,2-dpyrimidin-7-yl-2,2-dimethyl-, (3aR,4R,6S,6aS)-;(1S)-1-(7-N-benzyloxyMethyl-9-deaza-6-O-Methylhypoxanthin-9-yl)-1,4-dideoxy-1,4-iMino-2,3-O-isopropylidene-D-ribitol
• CAS NO: 299916-67-9
• Molecular Formula: C₂₃H₂₈N₄O₅
• Molecular Weight: 440.49
• Mol File: 299916-67-9.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4H-1,3-Dioxolo4,5-cpyrrole-4-methanol, tetrahydro-6-4-methoxy-5-(phenylmethoxy)methyl-5H-pyrrolo3,2-dpyrimidin-7-yl-2,2-dimethyl-, (3aR,4R,6S,6aS)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4H-1,3-Dioxolo4,5-cpyrrole-4-methanol, tetrahydro-6-4-methoxy-5-(phenylmethoxy)methyl-5H-pyrrolo3,2-dpyrimidin-7-yl-2,2-dimethyl-, (3aR,4R,6S,6aS)-(299916-67-9)
• EPA Substance Registry System: 4H-1,3-Dioxolo4,5-cpyrrole-4-methanol, tetrahydro-6-4-methoxy-5-(phenylmethoxy)methyl-5H-pyrrolo3,2-dpyrimidin-7-yl-2,2-dimethyl-, (3aR,4R,6S,6aS)-(299916-67-9)

Safety Data

• Hazardous Substances Data: 299916-67-9(Hazardous Substances Data)

Upstream product

• 1185908-34-2 C₂₃H₂₆N₄O₅ 
• 299916-62-4 7-N-benzyloxymethyl-9-bromo-9-deaza-6-O-methylhypoxanthine 
• 1026012-16-7 5-(benzyloxymethyl)-4-methoxy-5H-pyrrolo[3,2-d]pyrimidine 
• 84905-80-6 4-Chloro-5H-pyrrolo[3,2-d]pyrimidine 
• 5655-01-6 9-deazahypoxanthine 
• 364046-18-4 1S-5-O-tert-butyldimethylsilyl-1,4-dideoxy-1-C-[(4-methyoxypyrrolo[3,2-d]pyrimidin-9-N-(benzyloxomethyl)-7-yl)]-1,4-imino-2,3-O-isopropylidine-D-ribitol 

Downstream Products

• 209799-67-7 forodesine 

Relevant articles and documents

Alternative route towards the convergent synthesis of a human purine nucleoside phosphorylase inhibitor-forodesine HCl

Forodesine HCl is being investigated as a potential target for the control of T-cell proliferation. Herein we present an alternative route for the synthesis of the target molecule with addition of lactam to the lithiated deazahypoxanthine (generated in situ). The lactam was synthesized in five steps starting from l-pyroglutamic acid.

Process for preparing 2-pyrrolidinyl-1H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside metabolism

A process of preparing a compound of the formula (I) wherein B is chosen from OH, NH2, NHR, H or halogen; D is chosen from OH, NH2, NHR, H halogen or SCH3; R is an optionally substituted alkyl, aralkyl or aryl group; and Z is selected from OH, hydrogen, halogen, hydroxy, SQ or OQ, Q is an optionally substituted all, aralkyl or aryl group; or a tautomer thereof; or a pharmaceutically acceptable salt thereof; or an ester thereof; or a prodrug thereof, which comprises reacting a compound of the formula (II) ?with an anion produced by abstraction of the bromine or iodine atom from a compound of formula (XIX), ?to form a compound of formula (XX) The compound of formula (XX) is N- and O-deprotected to obtain the compound of formula (I).

Addition of lithiated 9-deazapurine derivatives to a carbohydrate cyclic imine: Convergent synthesis of the aza-C-nucleoside immucillins

Means have been developed for the synthesis and addition of 9-deaza-9-lithiopurine derivatives to the carbohydrate-derived cyclic imine 6 in facile convergent syntheses of biologically active aza-C-nucleosides.